In September, Health Secretary Robert F. Kennedy Jr. unveiled a comprehensive federal plan aimed at improving the health of American children, titled “Make Our Children Healthy Again.” The initiative outlined more than 100 objectives to address key challenges such as poor diet, chemical exposure, lack of physical activity and chronic stress, and overmedicalization. Nearly a year after its release, progress on the administration’s promises remains uneven, with some measures implemented and others stalled or contradicted by policy decisions.
On the issue of poor diet, the administration introduced updated dietary guidelines recommending a reduction in highly processed foods, a move welcomed by many health experts. However, the guidelines’ emphasis on meat and whole milk drew criticism due to perceived conflicts of interest involving dairy and meat industry ties during their development. The administration has approved policies in 23 states restricting the use of Supplemental Nutrition Assistance Program (SNAP) dollars for sugary items like sodas and candies, though efforts to implement these have faced legal challenges in some states. Additionally, the Food and Drug Administration (FDA) proposed requiring manufacturers to disclose all food ingredients to address the “Generally Recognized as Safe” (GRAS) loophole, though experts question whether the agency has sufficient resources to evaluate these substances effectively.
Efforts to define ultraprocessed foods at the federal level, originally targeted for completion by 2025, remain under review amid opposition from food industry groups. Meanwhile, the White House has permitted schools to serve whole milk and is considering revisions to school meal standards to increase the inclusion of “real food,” though details and impacts remain forthcoming. Conversely, the Agriculture Department canceled over $1 billion in funding for purchasing fresh foods from local farms and reduced SNAP benefits, affecting millions, including children. The administration also eliminated the SNAP-Ed program, which provided nutrition education and obesity prevention services.
Regarding chemical exposures, federal investments have been made in research on pesticides, microplastics, and their links to chronic disease, with funding announcements totaling hundreds of millions of dollars. The Environmental Protection Agency (EPA) has proposed listing microplastics and pharmaceuticals as priority water pollutants, potentially enabling more research, though the rule is not finalized. Conversely, the administration has rolled back certain air quality regulations, including easing limits on smog-producing emissions from trucks, and moved to repeal restrictions on per- and polyfluoroalkyl substances (PFAS) in drinking water—chemicals associated with developmental delays and cancer risks. An executive order supporting increased glyphosate production, a herbicide with contested safety profiles, was also issued.
In the area of physical activity and mental health, President Trump reinstated the Presidential Fitness Test, though participation remains voluntary and state readiness is limited. The surgeon general issued warnings about screen time for children, promoting delayed exposure as a preventive measure. While some research into these areas has received funding, mental health initiatives faced cuts, including significant reductions to Medicaid programs covering pediatric services and the suspension of $1 billion allocated to improve school mental health services following the 2022 Uvalde school shooting. Legal challenges have since mandated partial restoration of these funds. At the same time, policies facilitating access to flavored e-cigarettes, despite concerns about their link to youth anxiety and depression, have raised further public health questions.
On concerns over overmedicalization, the administration sought to modify the childhood vaccination schedule and scale back the use of psychiatric drugs among children. Several executive orders attempted to reduce routine vaccine recommendations, moves that have been blocked in court due to health concerns. Efforts to promote tapering off antidepressants have received mixed reactions from mental health professionals, with some welcoming clearer guidelines and others cautioning against potential stigmatization. The FDA has also targeted misleading prescription drug advertising, sending warning letters to companies promoting medications for conditions such as attention deficit disorder in children.
While the administration touts its reforms as historic and transformative, experts and officials remain divided on their scientific basis and potential health impacts. Some initiatives, such as restrictions on sugary food purchases and enhanced ingredient transparency, have been praised, whereas cuts to nutrition and mental health funding, regulatory rollbacks, and vaccination-related actions have sparked criticism for possibly undermining child health outcomes. The overall effectiveness of the plan continues to hinge on forthcoming policy decisions, court rulings, and implementation efforts.